117 related articles for article (PubMed ID: 2656706)
1. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
Yu G; Smithgall TE; Glazer RI
J Biol Chem; 1989 Jun; 264(17):10276-81. PubMed ID: 2656706
[TBL] [Abstract][Full Text] [Related]
2. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells.
Smithgall TE; Yu G; Glazer RI
J Biol Chem; 1988 Oct; 263(29):15050-5. PubMed ID: 3170574
[TBL] [Abstract][Full Text] [Related]
3. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
Fang F; Ahmad S; Lei J; Klecker RW; Trepel JB; Smithgall TE; Glazer RI
Biochemistry; 1993 Jul; 32(27):6995-7001. PubMed ID: 8334128
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
Smithgall TE; Johnston JB; Bustin M; Glazer RI
J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-Fes protein isoforms correlates with differentiation in myeloid leukemias.
Carlson A; Berkowitz JM; Browning D; Slamon DJ; Gasson JC; Yates KE
DNA Cell Biol; 2005 May; 24(5):311-6. PubMed ID: 15869408
[TBL] [Abstract][Full Text] [Related]
6. p210Bcr/Abl and p160v-Abl induce an increase in the tyrosine phosphorylation of p93c-Fes.
Ernst TJ; Slattery KE; Griffin JD
J Biol Chem; 1994 Feb; 269(8):5764-9. PubMed ID: 8119916
[TBL] [Abstract][Full Text] [Related]
7. Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
Yu G; Grant S; Glazer RI
Mol Pharmacol; 1988 Apr; 33(4):384-8. PubMed ID: 3162757
[TBL] [Abstract][Full Text] [Related]
8. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation.
Ferrari S; Manfredini R; Tagliafico E; Grande A; Barbieri D; Balestri R; Pizzanelli M; Zucchini P; Citro G; Zupi G
Leukemia; 1994 Apr; 8 Suppl 1():S91-4. PubMed ID: 8152313
[TBL] [Abstract][Full Text] [Related]
9. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
Lionberger JM; Smithgall TE
Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of c-Fes in myeloid leukemia cells.
He Y; Borellini F; Koch WH; Huang KX; Glazer RI
Biochim Biophys Acta; 1996 May; 1306(2-3):179-86. PubMed ID: 8634335
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
12. Increased DNA binding and transcriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene.
Borellini F; He YF; Aquino A; Yu G; Josephs SF; Glazer RI
J Biol Chem; 1991 Aug; 266(24):15850-4. PubMed ID: 1874737
[TBL] [Abstract][Full Text] [Related]
13. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.
Heydemann A; Juang G; Hennessy K; Parmacek MS; Simon MC
Mol Cell Biol; 1996 Apr; 16(4):1676-86. PubMed ID: 8657143
[TBL] [Abstract][Full Text] [Related]
14. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
15. The c-Fes family of protein-tyrosine kinases.
Smithgall TE; Rogers JA; Peters KL; Li J; Briggs SD; Lionberger JM; Cheng H; Shibata A; Scholtz B; Schreiner S; Dunham N
Crit Rev Oncog; 1998; 9(1):43-62. PubMed ID: 9754447
[TBL] [Abstract][Full Text] [Related]
16. Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously.
Brach MA; Gauer E; Ludwig WD; Ganser A; Mertelsmann R; Herrmann F
Int J Cell Cloning; 1991 Jan; 9(1):89-94. PubMed ID: 2010659
[TBL] [Abstract][Full Text] [Related]
17. Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells.
Manfredini R; Balestri R; Tagliafico E; Trevisan F; Pizzanelli M; Grande A; Barbieri D; Zucchini P; Citro G; Franceschi C; Ferrari S
Blood; 1997 Jan; 89(1):135-45. PubMed ID: 8978286
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
19. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.
Kim J; Feldman RA
Mol Cell Biol; 2002 Mar; 22(6):1903-18. PubMed ID: 11865067
[TBL] [Abstract][Full Text] [Related]
20. Human c-FES is a nuclear tyrosine kinase.
Yates KE; Lynch MR; Wong SG; Slamon DJ; Gasson JC
Oncogene; 1995 Mar; 10(6):1239-42. PubMed ID: 7700650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
